SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
Authors:
Open Access
- 28 August 2018
- journal article
- research article
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2018, 1-6
Abstract
Background and Objective. Serine hydroxymethyltransferase 2 (SHMT2) functions as a key enzyme in serine/glycine biosynthesis and one-carbon metabolism. Recent studies have shown that SHMT2 participated in tumor growth and progression in a variety of cancer types. The objective of the present study is to explore the expression of SHMT2 and evaluate its prognostic value in patients with intrahepatic cholangiocarcinoma (iCCA).Patients and Methods.We retrospectively investigated the expression of SHMT2 in 100 primary iCCA samples through immunohistochemical (IHC) staining on a tissue array.Results.High SHMT2 expression was found in 52 of the 100 specimens. The results indicated that SHMT2 level was upregulated compared to adjacent nontumor intrahepatic bile duct tissue. Furthermore, SHMT2 level was closely associated with tumor T stage () and tumor TNM stage () in patients with iCCA, but not with age, gender, tumor size, tumor number, pathological grade, vascular invasion, or N stage. Moreover, Kaplan-Meier analysis suggested that patients with lower SHMT2 level have longer survival rate than those with high expression (45.8 vs 23.1%,). Additionally, the multivariate analysis model indicated SHMT2 is an independent adverse prognosticator in iCCA.Conclusion.High SHMT2 level was correlated with poorer overall survival in patients with iCCA. SHMT2 was proved to be a powerful and independent prognostic factor and a potential therapeutic target for patients with iCCA.
Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2017BC032, 31701013)
- National Natural Science Foundation of China (ZR2017BC032, 31701013)
This publication has 25 references indexed in Scilit:
- Serine, glycine and one-carbon units: cancer metabolism in full circleNature Reviews Cancer, 2013
- Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell ProliferationScience, 2012
- Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and TumorigenesisCell, 2012
- Clinical diagnosis and staging of cholangiocarcinomaNature Reviews Gastroenterology & Hepatology, 2011
- SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate BiosynthesisPLOS ONE, 2009
- Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database AnalysisJournal of Gastrointestinal Surgery, 2007
- CholangiocarcinomaAnnals of Surgery, 2007
- Chemotherapy and the war on cancerNature Reviews Cancer, 2005
- The Epidemiology of CholangiocarcinomaSeminars in Liver Disease, 2004
- Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?Journal of Hepatology, 2004